Form 4: Twist Bioscience SVP of Human Resources, Paula Green, Acquires Shares Through RSU Vesting

Paula Green, SVP of Human Resources at Twist Bioscience, acquired 20,428 shares of common stock through the vesting of a restricted stock unit award.

Summary

• Paula Green, the Senior Vice President of Human Resources at Twist Bioscience, has acquired 20,428 shares of the company's common stock.
• This acquisition occurred on December 4, 2024, through the vesting of a restricted stock unit (RSU) award.
• The RSU award vests in 1/16th increments on each quarterly anniversary of November 20, 2024, over a total vesting period of 48 months.
• The shares were acquired at a price of $0, indicating they were received as part of the vesting schedule rather than a direct purchase.
• Following this transaction, Paula Green now beneficially owns 134,575 shares of Twist Bioscience common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The vesting of RSUs aligns the interests of the executive with the long-term performance of the company.
• The increase in share ownership demonstrates the executive's commitment to the company.

Industry Context

This is a standard practice for executive compensation in publicly traded companies, using equity to align management's interests with shareholders.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) for executive compensation is a common practice among publicly traded biotechnology companies like Twist Bioscience.
• Companies such as Illumina, Agilent, and Thermo Fisher Scientific also utilize similar equity-based compensation plans to incentivize their executives.
• The vesting schedule of 48 months is also typical, ensuring long-term commitment from the executive.
• The specific number of shares and vesting terms would be specific to the individual's employment agreement and performance.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.
• The vesting of RSUs is a standard part of executive compensation and does not have a significant impact on other stakeholders.

Key Dates

Keywords

Twist Bioscience, RSU, stock vesting, Paula Green, executive compensation, share ownership, Form 4